Swanand Kulkarni

7PUBLICATIONS
22CO-AUTHORS
ChemotherapyMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 12, 2025
Animal models of polycystic ovary syndrome.

Swanand Kulkarni, Dnyanesh Dahake, Khushi Gupta

|Sep 15, 2023
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.

Rakesh Khator, Avadh Biharee, Neha Bhatia

|Sep 12, 2023
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors.

Yogesh Singh, Niraj Kumar, Swanand Kulkarni

|Feb 06, 2023
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors.

Swanand Kulkarni, Yogesh Singh, Avadh Biharee

|Dec 05, 2022
Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.

Pooja Ratre, Swanand Kulkarni, Sweety Das

|Sep 27, 2022
Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations.

Avadh Biharee, Arpita Yadav, Kailash Jangid

Pageof 2

Frequent Collaborators

7 joint publications

Suresh Thareja

5 joint publications

Yogesh Singh

3 joint publications

Avadh Biharee

2 joint publications

Pradeep Kumar